Véronique Mansat-De Mas

18PUBLICATIONS
171CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersHaematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 24, 2026
A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Ekaterini Himonas, Lucie de Beauchamp, Désirée Zerbst

|Jun 25, 2025
Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML.

Aristi Damaskou, Rachael Wilson, Malgorzata Gozdecka

|Jun 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patients.

Olivier Mansier, Eric Lippert, Lina Benajiba

|Nov 06, 2023
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.

Vincent Fregona, Manon Bayet, Mathieu Bouttier

|Jul 09, 2023
Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms.

Charly Courdy, Loïc Platteeuw, Charlotte Ducau

|Jun 16, 2023
CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia.

Thomas Farge, Jean Nakhle, Damien Lagarde

Pageof 3

Frequent Collaborators

10 joint publications

Christian Récher

8 joint publications

Jean-Emmanuel Sarry

7 joint publications

François Vergez

6 joint publications

Sarah Bertoli